NASDAQ:LXEO

Lexeo Therapeutics, Inc.

Read LXEO's Filings Free

Company facts

Headquarters
New York, New York
Most recent report
10-Q, filed Aug 12, 2026
Filings on record
352 filings
On EDGAR
CIK 1907108
Fiscal year ends
December
Filer status
Non-accelerated filer Smaller reporting company Emerging growth company

Financials 8 of 13

News 8 of 36

Prospectuses and Registrations 8 of 37

Proxies 7

Ownership 8 of 220

Other 8 of 39

Everything here comes from Lexeo Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.